Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7054) 7054
Book Chapter (47) 47
Publication (16) 16
Magazine Article (10) 10
Newsletter (6) 6
Dissertation (5) 5
Newspaper Article (5) 5
Conference Proceeding (3) 3
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5376) 5376
science & technology (4259) 4259
life sciences & biomedicine (4189) 4189
male (3583) 3583
female (3175) 3175
octreotide - therapeutic use (2974) 2974
octreotide (2601) 2601
biological and medical sciences (2455) 2455
middle aged (2451) 2451
medical sciences (2257) 2257
adult (2254) 2254
aged (1679) 1679
octreotide - analogs & derivatives (1560) 1560
animals (1371) 1371
somatostatin - analogs & derivatives (1353) 1353
pharmacology. drug treatments (1210) 1210
octreotide - pharmacology (1166) 1166
somatostatin (1112) 1112
endocrinology & metabolism (1098) 1098
octreotide - administration & dosage (1068) 1068
abridged index medicus (844) 844
treatment outcome (839) 839
somatostatin - therapeutic use (796) 796
oncology (766) 766
rats (738) 738
acromegaly - drug therapy (649) 649
gastroenterology & hepatology (639) 639
receptors, somatostatin - metabolism (610) 610
tumors (603) 603
octreotide - adverse effects (601) 601
antineoplastic agents, hormonal - therapeutic use (595) 595
radionuclide imaging (583) 583
medicine & public health (570) 570
surgery (541) 541
hormones. endocrine system (458) 458
radiology, nuclear medicine & medical imaging (453) 453
acromegaly (448) 448
octreotide - pharmacokinetics (436) 436
aged, 80 and over (432) 432
pharmacology & pharmacy (428) 428
time factors (406) 406
somatostatin - pharmacology (394) 394
gastrointestinal agents - therapeutic use (380) 380
fundamental and applied biological sciences. psychology (369) 369
endocrinopathies (366) 366
mice (364) 364
indium radioisotopes (361) 361
radiopharmaceuticals (350) 350
adolescent (336) 336
tomography, x-ray computed (334) 334
general & internal medicine (327) 327
neuroendocrine tumors - diagnostic imaging (315) 315
pentetic acid - analogs & derivatives (315) 315
neuroendocrine tumors (311) 311
medicine, general & internal (310) 310
retrospective studies (306) 306
radiopharmaceuticals - therapeutic use (305) 305
pituitary neoplasms - drug therapy (299) 299
care and treatment (295) 295
digestive system (295) 295
neuroendocrine tumors - radiotherapy (294) 294
prospective studies (292) 292
dose-response relationship, drug (283) 283
pancreatic neoplasms - drug therapy (274) 274
receptors, somatostatin - analysis (271) 271
antineoplastic agents - therapeutic use (267) 267
growth hormone - blood (267) 267
magnetic resonance imaging (267) 267
neuroendocrine tumors - pathology (256) 256
peptides, cyclic - therapeutic use (248) 248
health aspects (247) 247
adenoma - drug therapy (246) 246
insulin-like growth factor i - metabolism (245) 245
follow-up studies (243) 243
liver neoplasms - secondary (243) 243
neuroendocrine tumors - drug therapy (239) 239
acromegaly - blood (234) 234
chemotherapy (230) 230
neurosciences & neurology (230) 230
cancer (229) 229
octreotide acetate (226) 226
peptides (226) 226
gastroenterology. liver. pancreas. abdomen (222) 222
non tumoral diseases. target tissue resistance. benign neoplasms (222) 222
injections, subcutaneous (221) 221
organometallic compounds - therapeutic use (218) 218
octreotide - chemistry (217) 217
antineoplastic agents (215) 215
tissue distribution (214) 214
vertebrates: endocrinology (211) 211
radiopharmaceuticals - pharmacokinetics (207) 207
pancreatic neoplasms - pathology (205) 205
delayed-action preparations (204) 204
octreotide - metabolism (204) 204
tomography, emission-computed, single-photon (204) 204
insulin - blood (202) 202
somatostatin - administration & dosage (202) 202
combined modality therapy (201) 201
hypothalamus. hypophysis. epiphysis (201) 201
analysis (200) 200
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6817) 6817
German (93) 93
Japanese (75) 75
French (66) 66
Spanish (56) 56
Italian (39) 39
Chinese (32) 32
Russian (25) 25
Hungarian (23) 23
Portuguese (19) 19
Polish (15) 15
Korean (14) 14
Danish (7) 7
Czech (5) 5
Hebrew (4) 4
Croatian (3) 3
Dutch (3) 3
Ukrainian (3) 3
Finnish (2) 2
Norwegian (2) 2
Afrikaans (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
by Dik J. Kwekkeboom and Wouter W. de Herder and Boen L. Kam and Casper H. van Eijck and Martijn van Essen and Peter P. Kooij and Richard A. Feelders and Maarten O. van Aken and Eric P. Krenning
Journal of clinical oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Somatostatin analogues for pancreatic surgery
by Gurusamy, Kurinchi Selvan and Koti, Rahul and Fusai, Giuseppe and Davidson, Brian R and Gurusamy, Kurinchi Selvan
Cochrane library, ISSN 1469-493X, 2013, Volume 2013, Issue 4, pp. CD008370 - CD008370
Length of Stay | Reoperation | Pancreatic Fistula | Gastroenterology & hepatology | Pancreatectomy | Octreotide | Pharmacology | Pancreaticoduodenectomy | Randomized Controlled Trials as Topic | Pancreatic Diseases | Treatment | Cancer: pancreas | Surgery | Publication Bias | Sepsis | Somatostatin | Pancreas | Medicine General & Introductory Medical Sciences | Postoperative Complications | Gastrointestinal Agents | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pancreatectomy - adverse effects | Sepsis - prevention & control | Somatostatin - analogs & derivatives | Pancreaticoduodenectomy - mortality | Humans | Postoperative Complications - prevention & control | Pancreas - metabolism | Postoperative Complications - mortality | Octreotide - therapeutic use | Pancreaticoduodenectomy - adverse effects | Pancreas - surgery | Pancreatectomy - mortality | Gastrointestinal Agents - therapeutic use | Reoperation - statistics & numerical data | Pancreatic Diseases - surgery | Pancreatic Fistula - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Resistance to Somatostatin Analogs in Acromegaly
by Colao, Annamaria and Auriemma, Renata S and Lombardi, Gaetano and Pivonello, Rosario
Endocrine reviews, ISSN 0163-769X, 04/2011, Volume 32, Issue 2, pp. 247 - 271
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Non tumoral diseases. Target tissue resistance. Benign neoplasms | Vertebrates: endocrinology | Hypothalamus. Hypophysis. Epiphysis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Pituitary Neoplasms - surgery | Somatostatin - analogs & derivatives | Adenoma - surgery | Humans | Treatment Outcome | Octreotide - therapeutic use | Pituitary Neoplasms - complications | Acromegaly - drug therapy | Acromegaly - etiology | Adenoma - complications | Peptides, Cyclic - therapeutic use | Somatostatin - therapeutic use | Drug Resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Somatostatin and its analogs
by Sun, Lichun and Coy, David H
Current drug targets, ISSN 1389-4501, 04/2016, Volume 17, Issue 5, pp. 529 - 537
Hormone | Somatostatin analogs | Somatostatin | Receptor-targeted | Somatostatin receptors | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Somatostatin - analogs & derivatives | Humans | Peptides, Cyclic - pharmacology | Clinical Trials as Topic | Octreotide - therapeutic use | Octreotide - pharmacology | Somatostatin - pharmacology | Acromegaly - drug therapy | Peptides, Cyclic - therapeutic use | Receptors, Somatostatin - antagonists & inhibitors | Cell Proliferation - drug effects | Somatostatin - therapeutic use | Somatostatin - metabolism | Cushing Syndrome - drug therapy
Journal Article
Details down arrow
5. Full Text Somatostatin analogues for pancreatic surgery
by Gurusamy, Kurinchi Selvan and Koti, Rahul and Fusai, Giuseppe and Davidson, Brian R
Cochrane database of systematic reviews, ISSN 1469-493X, 2012, Volume 6, Issue 6, pp. CD008370 - CD008370
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Length of Stay | Pancreatectomy - adverse effects | Sepsis - prevention & control | Humans | Postoperative Complications - prevention & control | Pancreas - metabolism | Octreotide - therapeutic use | Pancreaticoduodenectomy - adverse effects | Pancreas - surgery | Randomized Controlled Trials as Topic | Gastrointestinal Agents - therapeutic use | Publication Bias | Somatostatin - therapeutic use | Pancreatic Diseases - surgery | Pancreatic Fistula - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
by Caroli, Anna, PhD and Perico, Norberto, MD and Perna, Annalisa, MSc and Antiga, Luca, PhD and Brambilla, Paolo, MD and Pisani, Antonio, MD and Visciano, Bianca, MD and Imbriaco, Massimo, MD and Messa, Piergiorgio, MD and Cerutti, Roberta, MD and Dugo, Mauro, MD and Cancian, Luca, MD and Buongiorno, Erasmo, MD and De Pascalis, Antonio, MD and Gaspari, Flavio, ChemD and Carrara, Fabiola, Chemist and Rubis, Nadia, Res Nurse and Prandini, Silvia, Res Nurse and Remuzzi, Andrea, EngD and Remuzzi, Giuseppe, Dr and Ruggenenti, Piero, MD and for the ALADIN study group and ALADIN Study Grp and ALADIN study group
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9903, pp. 1485 - 1495
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | General aspects | Kidneys | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Malformations of the urinary system | Somatostatin - analogs & derivatives | Kidney - drug effects | Follow-Up Studies | Kidney - pathology | Cholecystitis, Acute - chemically induced | Humans | Middle Aged | Polycystic Kidney, Autosomal Dominant - pathology | Octreotide - adverse effects | Male | Treatment Outcome | Octreotide - therapeutic use | Disease Progression | Magnetic Resonance Imaging | Organ Size - drug effects | Kidney Failure, Chronic - prevention & control | Gastrointestinal Agents - therapeutic use | Adult | Female | Italy | Gastrointestinal Agents - adverse effects | Cholelithiasis - chemically induced | Polycystic Kidney, Autosomal Dominant - drug therapy | Care and treatment | Octreotide acetate | Health aspects | Polycystic kidney disease | Proteins | Studies | Cell growth | Liver diseases | Cysts | Rodents | Kidney diseases | Urogenital system | Blood | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights